FDA Panel Rejects New Uses For Cancer Drug
A U.S. Food and Drug Administration advisory committee has voted against approving the use of Cephalon Inc.'s pain-killer Fentora for noncancer patients with chronic pain....To view the full article, register now.
Already a subscriber? Click here to view full article